Shilpa Medicare Bengaluru unit gets TGA Australia nod for manufacturing medicinal Oral Mouth Dissolving Films Ruchika Sharma13 Dec 2023 1:30 PM ISTThis approval will enable the company to secure approval and market its Oral Film products in Australia.
Shilpa Medicare Jadcherla facility clears TGA, Australia GMP inspection Ruchika Sharma18 Oct 2023 2:30 PM ISTKarnataka: Shilpa Medicare has recently informed through a BSE filing that the Company’s finished dosage form manufacturing facility, Unit IV,...
Shilpa Pharma Lifesciences Unit II Raichur facility clears PMDA Japan GMP inspection Ruchika Sharma3 Sept 2023 1:15 PM ISTKarnataka: Shilpa Medicare Limited has announced that PMDA, Japan has successfully concluded GMP inspection without any critical/major observation at...
Shilpa Medicare receives UK-MHRA marketing nod for Betahistine Dihydrochloride Orodispersible Films Ruchika Sharma2 Sept 2023 1:30 PM ISTBetahistine is indicated for the treatment of vertigo, tinnitus, hearing loss and nausea associated with Meniere's syndrome and is available as...
Shilpa Biologicals gets marketing authorization permission for Adalimumab 40 mg/0.4mL injection in prefilled syringe in India Ruchika Sharma30 Jun 2023 12:30 PM ISTKarnataka: Shilpa Biologicals Private Limited (SBPL), a wholly owned subsidiary of Shilpa Medicare Limited (SML), has received the Marketing...
Shilpa Medicare gets USFDA VAI status for Hyderabad unit Ruchika Sharma22 May 2023 2:43 PM ISTKarnataka: Shilpa Medicare has announced that the US FDA GMP inspection performed on Company’s Analytical Services Division situated on first...
Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay Ruchika Sharma11 April 2023 1:00 PM ISTKarnataka: Shilpa Medicare has recently announced that the Company has received final approval from the U.S Food and Drug...
Shilpa Medicare Analytical Services Division gets 2 minor observations from USFDA Ruchika Sharma11 March 2023 2:00 PM ISTKarnataka: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has closed the inspection with two minor observations at the...
Shilpa Medicare Bengaluru facility gets registered with Ministry of Health, UAE Ruchika Sharma18 Feb 2023 10:00 AM ISTThe GMP facility is equipped with state of art machinery for the needs of Global commercial requirements.
Shilpa Medicare unveils Capecitabine 1000 MG dispersible tablet for breast cancer Ruchika Sharma22 Dec 2022 2:00 PM ISTWith the introduction of Shilpa's new brand, "Capebel", patients will be required to just drop the tablets in 100 mL water and allow the tablets to...
Shilpa Medicare gets Health Canada GMP approval for Jadcherla facility Ruchika Sharma5 Dec 2022 12:30 PM ISTKarnataka: Shilpa Medicare has recently announced that the Company's finished dosage form manufacturing facility, Unit IV, situated at Pharma...
Shilpa Medicare Hyderabad division gets USFDA clearance Ruchika Sharma23 Sept 2022 12:15 PM ISTThe USFDA clearance on the facility will enable the company to test and release batches into the US from this facility.
